Drug Markets/Terbinafine

Terbinafine

5 NDCs across 3 manufacturers|5 Generic,0 Brand

Terbinafine is used to treat chronic mucocutaneous candidiasis, onychomycosis, tinea capitis, tinea pedis and tinea versicolor, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Apr 29, 1998.

Terbinafine is available as 5 NDCs from 3 manufacturers (5 generic, 0 brand), with NADAC prices from $0.14 to $0.18 per EA — a 23% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

5

5G / 0B

Manufacturers

3

competing in market

Price Spread

$0.14 – $0.18

per EA

7d Activity

4↑1 flat

avg +5.2% WoW · of 5 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

5 NDCs total, 5 shown

Frequently Asked Questions

What is Terbinafine used to treat?

Terbinafine is used to treat chronic mucocutaneous candidiasis, onychomycosis, tinea capitis, tinea pedis and tinea versicolor, per the National Library of Medicine's MED-RT classification.

How many Terbinafine products are on the market?

The Terbinafine drug market contains 5 NDCs from 3 manufacturers — 5 generic and 0 brand products.

What is the price range for Terbinafine?

NADAC reference prices for Terbinafine range from $0.1426 to $0.1761 per EA — a 23% difference between cheapest and most expensive.

Which manufacturers make Terbinafine?

3 manufacturers list Terbinafine in NADAC. Ranked by number of NDCs, the largest are Chartwell RX LLC (2), Cipla USA Inc. (2), Exelan Pharmaceuticals Inc. (1).

How has the price of Terbinafine changed recently?

Over the past 7 days, 4 Terbinafine NDCs rose and 0 fell, with a market-wide average change of +5.2%.